A Randomized Phase 3 Trial of ALIMTA and Cisplatin Versus GEMZAR and Cisplatin in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
A Randomized Phase 3 Trial of ALIMTA and Cisplatin Versus GEMZAR and Cisplatin in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
This study is a randomized Phase 3 study comparing pemetrexed and cisplatin combination to gemcitabine and cisplatin for the treatment of Non Small Cell Lung Cancer (NCSLC). Gemcitabine plus cisplatin is currently the standard of care for NSCLC. It is thought that pemetrexed plus cisplatin may be as effective and may have fewer side effects than the standard of care.
Inclusion Criteria:
Exclusion Criteria:
Sacramento, California, United States
Torrance, California, United States
Jacksonville, Florida, United States
Macon, Georgia, United States
Wichita, Kansas, United States
Lexington, Kentucky, United States
Scarborough, Maine, United States
Duluth, Minnesota, United States
St Louis, Missouri, United States
Billings, Montana, United States
Hackensack, New Jersey, United States
Hickory, North Carolina, United States
Portland, Oregon, United States
Columbia, South Carolina, United States
Nashville, Tennessee, United States
Arlington, Texas, United States
Richmond, Virginia, United States
Seattle, Washington, United States
Bahía Blanca, Argentina
Buenos Aires, Argentina
Bedford Park, Australia
Camperdown, Australia
Chermisdie, Australia
Fitzroy, Australia
Hornsby, Australia
Nedlands, Australia
South Brisbane, Australia
St Leonards, Australia
Graz, Austria
Grimmenstein, Austria
Innsbruck, Austria
Leoben, Austria
Linz, Austria
Sankt Pölten, Austria
Vienna, Austria
Wels, Austria
Leuven, Belgium
Liège, Belgium
Florianópolis, Brazil
Porto Alegre, Brazil
Rio de Janeiro, Brazil
Salvador, Brazil
São Paulo, Brazil
North Vancouver, British Columbia, Canada
Brampton, Ontario, Canada
Toronto, Ontario, Canada
Sainte-Foy, Quebec, Canada
Herlev, Denmark
Odense, Denmark
Helsinki, Finland
Tampere, Finland
Bordeaux, France
Grenoble, France
Marseille, France
Montpellier, France
Paris, France
Saint-Herblain, France
Strasbourg, France
Vandœuvre-lès-Nancy, France
Mannheim, Germany
Athens, Greece
Heraklion, Greece
Pátrai, Greece
Budapest, Hungary
Deszk, Hungary
Pécs, Hungary
Bangalore, India
Hyderabad, India
Kochi, India
Mumbai, India
New Dehli, India
Pune, India
Kfar Saba, Israel
Tel Aviv, Israel
Tel Litwinsky, Israel
Ancona, Italy
Bergamo, Italy
Bologna, Italy
Forlì, Italy
Genova, Italy
Livorno, Italy
Modena, Italy
Orbassano, Italy
Roma, Italy
Taormina, Italy
Ciudad Obregón, Mexico
Guadalajara, Mexico
León, Mexico
Mexicali, Mexico
Mexico City, Mexico
's-Hertogenbosch, Netherlands
Alkmaar, Netherlands
Amstelveen, Netherlands
Amsterdam, Netherlands
Arnhem, Netherlands
Eindhoven, Netherlands
Harderwijk, Netherlands
Heerlen, Netherlands
Krakow, Poland
Lodz, Poland
Szczecin-Zdunowo, Poland
Warsaw, Poland
Coimbra, Portugal
Lisbon, Portugal
Porto, Portugal
Santa Maria da Feira, Portugal
San Juan, Puerto Rico
Goyang-si, South Korea
Seoul, South Korea
Alicante, Spain
Badalona, Spain
Barcelona, Spain
Madrid, Spain
Pamplona, Spain
Sabadell, Spain
Santander, Spain
Zaragoza, Spain
Gothenburg, Sweden
Lund, Sweden
Stockholm, Sweden
Niao Sung Hsiang, Taiwan
Taichung, Taiwan
Taipei, Taiwan
Taoyuan, Taiwan
Ankara, Turkey (Türkiye)
Antalya, Turkey (Türkiye)
Istanbul, Turkey (Türkiye)
Izmir, Turkey (Türkiye)
Aberdeen, United Kingdom
Bangor, United Kingdom
Chelmsford, United Kingdom
Fulham, United Kingdom
Plymouth, United Kingdom